Mast cell activation syndrome: Global perspectives from a World Allergy Organization survey on knowledge, diagnosis, and access to care

Background

Mast Cell Activation Syndrome (MCAS) has emerged as a highly debated and increasingly recognized condition in allergy and clinical immunology. Despite established AIM/ECNM consensus criteria, major uncertainties persist regarding its diagnosis, implementation in real-world practice, and equitable access to diagnostic resources worldwide.